Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021

Rhea-AI Summary

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is set to release its first quarter 2021 results after market close on May 5, 2021. A conference call will follow at 4:30 PM ET to discuss the financial and operational results. Shareholders and interested parties can access details via dial-in numbers or through a live webcast. Tandem Diabetes is known for its innovative insulin delivery solutions, particularly the t:slim X2™ insulin pump that features remote software updates and integrated continuous glucose monitoring.

Positive

• Upcoming Q1 2021 earnings release after market close on May 5, 2021.
• Conference call scheduled to discuss financial and operational results.

Negative

• None.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2021 results after the financial markets close on Wednesday, May 5, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2021 financial and operating results.

Conference Call/Webcast Details:
Date: May 5, 2021
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 8046918
Webcast Link: https://edge.media-server.com/mmc/p/tz4ptaur

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210406005855/en/

FAQ

When will Tandem Diabetes Care announce its Q1 2021 results?

Tandem Diabetes Care will announce its Q1 2021 results on May 5, 2021, after market close.

What time is the Tandem Diabetes Care Q1 2021 conference call?

The conference call will take place at 4:30 PM Eastern Time on May 5, 2021.

How can I access the Tandem Diabetes Care conference call?

You can access the conference call via the toll-free dial-in number (855) 427-4396 or international dial-in number (484) 756-4261.

What is the ticker symbol for Tandem Diabetes Care?

The ticker symbol for Tandem Diabetes Care is TNDM.

Where can I find the webcast of the Tandem Diabetes Care earnings call?

The webcast can be found at the following link: https://edge.media-server.com/mmc/p/tz4ptaur.